Genetic Disorders
BRCA1/2 Hereditary Breast Cancer
가족성유방암 BRCA
BRCA1 (17q21) or BRCA2 (13q12) mutation - elevated breast/ovarian cancer risk (AD)
- How common
- Rare but important
- Typical age
- Often pediatric/young adult onset
What is it?
Genetic cause and core pathophysiology of BRCA1/2 Hereditary Breast Cancer (Autosomal dominant (BRCA1/BRCA2)).
Commonly affected: breast/ovary
How it develops
- Genetic mutationAutosomal dominant (BRCA1/BRCA2) pattern mutation
- Protein/enzyme defectDefective protein loses normal function
- Cellular consequenceTissue-specific changes occur in breast/ovary
- Clinical manifestationCharacteristic clinical features appear
Symptoms
- Characteristic featuresClassic BRCA1/2 Hereditary Breast Cancer presentation
- Organ-specific complicationsbreast/ovary involvement
- Progressive courseMay worsen over time
How it is examined
- History + pedigreeConfirm inheritance pattern
- Physical examIdentify specific phenotype
- Genetic testing (confirmatory)Confirm Autosomal dominant (BRCA1/BRCA2) mutation
Imaging
Imaging of affected organ as indicated.
- Disease-specific findings
MRI/CT to assess organ involvement when needed.
- Organ involvement
Non-surgical care
- Genetic counselingPatient + family counseling, prenatal options
- Symptomatic careTargeted symptom management
- Multidisciplinary follow-upCoordinate specialist care
- Enzyme/protein replacement (if applicable)ERT or analogous therapies
Conservative options are generally tried first. Medications listed here can have side effects — discuss them with your prescriber.
When surgery is considered
For complications or targeted therapy
Procedures that may be discussed
- Targeted pharmacotherapy (if available)
- Gene therapy (if available)
- Surgery for complications
Outlook
Early diagnosis and management improve quality of life.